Newsroom
A proposal to create a unit for stem cell treatments, including allogeneic transplants (where stem cells are taken from a donor), was presented today to the Parliamentary Committee on Health. The proposal, led by Committee Chairman Efthymios Diplaros and two other members of the ruling party, Charalambos Pazaros and Savia Orphanidou, aims to have a law drafted and approved by 2025.
This initiative responds to the approximately 30 patients who each year travel abroad for treatments, mainly for conditions like leukemia (a type of cancer that affects the blood) and thalassemia (a blood disorder). These patients face heavy financial and emotional burdens due to the need for overseas care. Having a dedicated unit in Cyprus would allow these patients to receive the same treatments locally, cutting down on the need for expensive trips abroad.
Diplaros explained that the bill would set clear standards for things like staff qualifications, the medical facilities and equipment required, and procedures to ensure high-quality care. He stressed that the planning process must be detailed and careful, with a full proposal expected by early October.
At present, autologous transplants (where a patient’s own stem cells are used) are available in Cyprus at three medical centers, but allogeneic transplants are only carried out abroad, mostly in Germany. The proposed unit would allow both types of transplants to be done in Cyprus, giving patients more options.
The proposal has received strong support, with AKEL MP Nikos Kettiros calling it an important step for improving healthcare and reducing the financial and emotional burden on families. DIPA MP Michalis Giakoumis also expressed support, viewing the bill as a step forward in providing better medical services in Cyprus.
